G1 Therapeutics, Inc.
GTHXDelisted Sep 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001560241
G1 Therapeutics, Inc. was delisted on Sep 18, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 88 institutions reported holding it in 13F filings for Q2 2024, worth $45.5M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding G1 Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 115 | 1 | 108 | −6 |
| Shares | 26.6M | 1.25K | 26.5M | −157.6K (−0.6%) |
| Value | $357.8M | $17.0K | $270.6M | −$87.2M (−24.4%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held G1 Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wellington Management Group LLP | 93,078 | $950.0K | 0.00% |
| Millennium Management LLC | 64,564 | $659.0K | 0.00% |
| Qube Research & Technologies Ltd | 31,447 | $321.0K | 0.00% |
| Jump Financial, LLC | 19,400 | $198.0K | 0.01% |
| Allspring Global Investments Holdings, LLC | 19,412 | $198.0K | 0.00% |
| Squarepoint Ops LLC | 14,839 | $152.0K | 0.00% |
| Guggenheim Capital LLC | 10,303 | $106.0K | 0.00% |
| Ensign Peak Advisors, Inc | 7,740 | $79.0K | 0.00% |
| CWM, LLC | 1,500 | $15.0K | 0.00% |
| National Bank of Canada | 1,000 | $10.0K | 0.00% |
| High Net Worth Advisory Group LLC | 1,000 | $10.0K | 0.00% |
| TCI Wealth Advisors, Inc. | 388 | $4.00K | 0.00% |
Sold out (18)
Institutions that held G1 Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Russell Investments Group, Ltd. | 156,507 | $2.10M |
| Alps Advisors Inc | 51,899 | $696.0K |
| DekaBank Deutsche Girozentrale | 46,900 | $695.0K |
| ETF Managers Group, LLC | 43,446 | $647.0K |
| Massachusetts Financial Services Co | 39,401 | $529.0K |
| Cubist Systematic Strategies, LLC | 27,560 | $370.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 26,211 | $352.0K |
| Towercrest Capital Management | 17,500 | $235.0K |
| Franklin Resources Inc | 16,556 | $222.0K |
| Los Angeles Capital Management LLC | 11,461 | $154.0K |
| Abbot Financial Management, Inc. | 10,650 | $143.0K |
| Exane Derivatives | 9,087 | $121.9K |
| Point72 Hong Kong Ltd | 6,363 | $85.0K |
| O'Shaughnessy Asset Management, LLC | 1,347 | $18.0K |
| Penserra Capital Management LLC | 965 | $12.0K |
| Global Retirement Partners, LLC | 100 | $1.00K |
| Center for Financial Planning, Inc. | 101 | $1.00K |
| First Horizon Advisors, Inc. | 13 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held G1 Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Sonora Investment Management, LLC | 1,250 | $17.0K |